/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Keryx Biopharmaceuticals Inc.\n \n\n\n\n\n
Nov 23 1:04 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 12, 2009 6:58 AM EST
\n\n \n RothmanResearch.com Market Review and Company Analysis on WMT, ARE, ENI, WL, ISRG and KERX - Marketwire\n \n \n
\n\n Nov 11, 2009 8:36 AM EST
\n\n \n Æterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology - CNW\n \n \n
\n\n Nov 11, 2009 8:36 AM EST
\n\n \n Æterna Zentaris: son partenaire Keryx Biopharmaceuticals fera une présentation sur affiche portant sur l'activité clinique de perifosine (KRX-0401) à la 51ième assemblée annuelle de l'American Society of Hematology - CNW\n \n \n
\n\n Nov 11, 2009 8:35 AM EST
\n\n \n AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology - PR Newswire\n \n \n
\n\n Nov 11, 2009 8:30 AM EST
\n\n \n Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology - PR Newswire\n \n \n
\n\n Nov 11, 2009 7:02 AM EST
\n\n \n Æterna Zentaris Reports Third Quarter 2009 Financial and Operating Results - CNW\n \n \n
\n\n Nov 11, 2009 7:01 AM EST
\n\n \n Æterna Zentaris annonce ses résultats financiers et d'exploitation du troisième trimestre de 2009 - CNW\n \n \n
\n
\n\n");